E-Articles
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Diseases > Multiple Sclerosis - Causes, Symptoms and Treatment

Tags

  • would
  • spinal
  • neurons
  • developing combination
  • developing combination
  • multiple sclerosis

  • Links

  • Fresh Flowers For Weddings
  • Pregnancy after Miscarriage ??“ Learning to Cope
  • Ways To Design An Interior For Your Home
  • E-Articles - Multiple Sclerosis - Causes, Symptoms and Treatment

    Multiple Sclerosis(MS)also known as disseminated sclerosis or encephalomyelitis disseminata is a chronic, inflammatory, demyelinating disease that affects the central nervous s
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ystem (CNS). Multiple sclerosis affects neurons, the cells of the brain and spinal cord that carry information, create thought and perception, and allow the brain to control th
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    body. Surrounding and protecting some of these neurons is a fatty layer known as the myelin sheath, which helps neurons carry electrical signals. MS causes gradual destruction
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    of myelin (demyelination) and transection of neuron axons in patches throughout the brain and spinal cord. The name multiple sclerosis refers to the multiple scars (or scleros
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    s) on the myelin sheaths. This scarring causes symptoms which vary widely depending upon which signals are interrupted. Multiple sclerosis (MS) usually affects woman more than
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    men. The disorder most commonly begins between ages 20 and 40, but can strike at any age. People with a family history of MS and those who live in a geographical area with a hi
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    her incidence rate for MS have a higher risk of the disease.

    Multiple sclerosis affects an estimated 300,000 people in the United States and probably more than 1 million peopl
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    e around the world — including twice as many women as men. Most people experience their first signs or symptoms between ages 20 and 40. MS can cause a variety of symptoms, incl
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    ding is changes in sensation, visual problems, muscle weakness, depression, difficulties with coordination and speech, severe fatigue, cognitive impairment, problems with balan
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ce, overheating, and pain. Multiple sclerosis may take several different forms, with new symptoms occurring either in discrete attacks or slowly accruing over time. Between att
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    cks, symptoms may resolve completely, but permanent neurologic problems often persist, especially as the disease advances. MS will cause impaired mobility and disability in mor
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    severe cases.

    Causes of Multiple Sclerosis

    1.Autoimmune disease.

    2.Genetic component.

    3.Damage to the Blood-Brain-Barrier.

    4.Biochemical events in utero.

    5.Allergic reac
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    tion

    6.Diet and vitamin deficiencies

    Symptoms of Multiple Sclerosis

    1.Double Vision

    2.Muscle weakness.

    3.Depression.

    4.Difficulties with coordination and speech.

    5.Overh
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    ating.

    6.Pain.

    Treatment of Multiple Sclerosis

    Several types of therapy have proven to be helpful. Different therapies are used for patients experiencing acute attacks, for
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    patients who have the relapsing-remitting subtype. Interferon medications derived from human cytokines which help regulate the immune system. Physical therapy, speech therapy,
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    ccupational therapy, and support groups can help improve the person's outlook, reduce depression, maximize function, and improve coping skills. Lioresal (Baclofen), tizanidine
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    (Zanaflex), or a benzodiazepine may be used to reduce muscle spasticity. Steroids are given to decrease the severity of attacks when they occur.

    These shut the immune system d
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    wn to stop cells from causing inflammation. Mitixantrone medication is effective, but is limited by cardiac toxicity. Interferon beta-1b (Betaseron) and interferon beta-1a (Avo
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    nex, Rebif) are genetically engineered copies of proteins that occur naturally in your body. They help fight viral infection and regulate your immune system. Glatiramer (Copaxo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    e) medication is an alternative to beta interferons if you have relapsing remitting MS. Doctors believe that glatiramer works by blocking your immune system's attack on myelin


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.e-article.org.ua/article/241497/e-article-Multiple-Sclerosis--Causes-Symptoms-and-Treatment.html">Multiple Sclerosis - Causes, Symptoms and Treatment</a>

    BB link (for phorums):
    [url=http://www.e-article.org.ua/article/241497/e-article-Multiple-Sclerosis--Causes-Symptoms-and-Treatment.html]Multiple Sclerosis - Causes, Symptoms and Treatment[/url]

    Related Articles:

    What About A Business To Business Franchise?

    Ten Tips for Today's Mobile Executive

    Michigan Real Estate Lawyers

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com